ABG Sundal Collier acted as Joint Bookrunner in the SEK 1,305m secondary sale of shares in Camurus

On 12 June 2025, Sandberg Development AB (“Sandberg Development”), the largest shareholder in the leading Swedish biotechnology company Camurus AB (“Camurus” or the “Company”), announced the successful completion of the sale of 2,250,000 shares in Camurus, representing approximately 3.6 percent of the total outstanding shares and votes in the Company (the “Transaction”). The share sale was completed through an accelerated bookbuilding process to a number of Swedish and international institutional investors and was priced at SEK 580 per share corresponding to a total deal size of approximately SEK 1,305m.
Following completion of the Transaction, Sandberg Development holds approximately 18.3 million shares in Camurus, representing approximately 30.7 percent of the total outstanding shares and votes, and thereby remains the largest shareholder in Camurus. In connection with the Transaction, Sandberg Development has entered into a lock-up agreement for 180 days. Thus, Sandberg Development remains a committed and long-term owner of the Company.
ABGSC acted as Joint Bookrunner in the Transaction and would like to express its gratitude to Sandberg Development for the vote of confidence.